Resultats de la cerca - Francesco Di Costanzo

  • Mostrar 1 - 19 resultats de 19
Refinar resultats
  1. 1
    Optimizing First-Line Chemotherapy in Metastatic Pancreatic Cancer: Efficacy of FOLFIRINOX versus Nab-Paclitaxel Plus Gemcitabine

    Optimizing First-Line Chemotherapy in Metastatic Pancreatic Cancer: Efficacy of FOLFIRINOX versus Nab-Paclitaxel Plus Gemcitabine per Francesco Di Costanzo, Federica Di Costanzo, Lorenzo Antonuzzo, Ernesto Mazza, Elisa Giommoni

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Primary Cardiac Angiosarcoma: A Fatal Disease

    Primary Cardiac Angiosarcoma: A Fatal Disease per Lorenzo Antonuzzo, Virginia Rotella, Francesca Mazzoni, Laura Doni, Diletta Bianchini, Francesca Garbini, V. Maio, Francesco Di Costanzo

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Chemotherapy of advanced non-small-cell lung cancer: A comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.)

    Chemotherapy of advanced non-small-cell lung cancer: A comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.) per Lucio Crinò, M. Clerici, F. Figoli, Paolo Carlini, Guido Ceci, Enrico Cortesi, A Carpi, Alessandra Santini, Francesco Di Costanzo, C. Boni

    Publicat 1995
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC)

    Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC) per Francesco Di Costanzo, Paolo Carlini, Laura Doni, B. Massidda, Rodolfo Mattioli, A. Iop, Emiddio Barletta, Luca Moscetti, F. Recchia, Paolo Tralongo, Silvia Gasperoni

    Publicat 2005
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Discontinuation rate and serious adverse events of chemoimmunotherapy as neoadjuvant treatment for triple-negative breast cancer: a systematic review and meta-analysis

    Discontinuation rate and serious adverse events of chemoimmunotherapy as neoadjuvant treatment for triple-negative breast cancer: a systematic review and meta-analysis per Alessandro Rizzo, Francesca Matilde Schipilliti, Francesco Di Costanzo, Silvana Acquafredda, Grazia Arpino, Fabio Puglisi, Lucia Del Mastro, Filippo Montemurro, Michelino De Laurentiis, Mario Giuliano

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  6. 6
    Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials

    Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials per Gunnar Folprecht, David Cunningham, Paul J. Ross, Bengt Glimelius, Francesco Di Costanzo, J. Wils, Werner Scheithauer, P Rougier, Enrique Aranda, Hartmut Hecker, C.-H. Köhne

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    hERG1 Channels and Glut-1 as Independent Prognostic Indicators of Worse Outcome in Stage I and II Colorectal Cancer: A Pilot Study

    hERG1 Channels and Glut-1 as Independent Prognostic Indicators of Worse Outcome in Stage I and II Colorectal Cancer: A Pilot Study per Elena Lastraioli, Lapo Bencini, Elisa Bianchini, Maria Raffaella Romoli, Olivia Crociani, Elisa Giommoni, Luca Messerini, Silvia Gasperoni, Renato Moretti‐Marques, Francesco Di Costanzo, Luca Boni, Annarosa Arcangeli

    Publicat 2012
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Clinical determinants of survival in patients with 5-fluorouracil- based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients

    Clinical determinants of survival in patients with 5-fluorouracil- based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients per C.-H. Köhne, David Cunningham, Francesco Di Costanzo, Bengt Glimelius, G.H. Blijham, Enrique Aranda, Werner Scheithauer, P. Rougier, M K Palmer, J. Wils, B. Barón, Francesco Pignatti, Patrick Schöffski, S. Micheel, Hartmut Hecker

    Publicat 2002
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Adjuvant Chemotherapy in Completely Resected Gastric Cancer: A Randomized Phase III Trial Conducted by GOIRC

    Adjuvant Chemotherapy in Completely Resected Gastric Cancer: A Randomized Phase III Trial Conducted by GOIRC per Francesco Di Costanzo, Silvia Gasperoni, L. Manzione, Giancarlo Bisagni, Roberto Labianca, Stefano Bravi, Enrico Cortesi, Paolo Carlini, R. Bracci, Federica Tomao, Luca Messerini, Annarosa Arcangeli, Valter Torri, D. Bilancia, Irene Floriani, Maurizio Tonato

    Publicat 2008
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological Factors

    Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological Factors per Francesca Spada, Lorenzo Antonuzzo, Riccardo Marconcini, Davide Radice, Andrea Antonuzzo, Sergio Ricci, Francesco Di Costanzo, Annalisa Fontana, Fabio Gelsomino, Gabriele Luppi, Elisabetta Nobili, Salvatore Galdy, Chiara Alessandra Cella, Angelica Sonzogni, Eleonora Pisa, Massimo Barberis, Nicola Fazio

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study

    Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study per Giuseppe Colucci, Roberto Labianca, Francesco Di Costanzo, Vittorio Gebbia, Giacomo Cartenì, B. Massidda, E. Dapretto, Luigi Manzione, Elena Piazza, Mirella Sannicolò, Marco Ciaparrone, Luigi Cavanna, Francesco Giuliani, Evaristo Maiello, Antonio Testa, Paolo Pederzoli, Massimo Falconi, Ciro Gallo, Massimo Di Maïo, Francesco Perrone

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Randomized Trial of Intravenous Iron Supplementation in Patients With Chemotherapy-Related Anemia Without Iron Deficiency Treated With Darbepoetin Alfa

    Randomized Trial of Intravenous Iron Supplementation in Patients With Chemotherapy-Related Anemia Without Iron Deficiency Treated With Darbepoetin Alfa per Paolo Pedrazzoli, A. Farris, Salvatore Del Prete, Filomena Del Gaizo, Daris Ferrari, Clara Bianchessi, Giuseppe Colucci, A Desogus, Teresa Gamucci, Alessandro Pappalardo, Giuseppe Fornarini, Paola Pozzi, Alessandra Fabi, Roberto Labianca, Francesco Di Costanzo, Simona Secondino, E. Crucitta, Federica Apolloni, Antonio Santo, Salvatore Siena

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma

    hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma per Elena Lastraioli, Giuseppe Perrone, Angelica Sette, Antonella Fiore, Olivia Crociani, Sagar S. Manoli, Massimo D’Amico, Marika Masselli, Jessica Iorio, Marcella Callea, Domenico Borzomati, Gennaro Nappo, Francesco Bartolozzi, Daniele Santini, Lapo Bencini, Mohammad Farsi, Luca Boni, Francesco Di Costanzo, A. Schwab, Andrea Onetti Muda, Roberto Coppola, Annarosa Arcangeli

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Preoperative staging of primary breast cancer.A multicentric study

    Preoperative staging of primary breast cancer.A multicentric study per Stefano Ciatto, P Pacini, Vincenzo Azzini, Alberto Neri, Annamaria Jannini, P Gosso, Annamaria Molino, Marco Capelli, Francesco Di Costanzo, M. Assunta Pucciatti, C Andreoli, Giuseppe Santoro, Gabriel Farante, Massimo Ciurli, A. Ramos da Costa, G. Brignone, Alberto Ravaioli, M. Scarpellini, Paolo Rosetti, Giuseppe Leo, Clelia Punzo, Vincenzo Oliva

    Publicat 1988
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis

    CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis per Masatoshi Kudo, Ana Matilla, Armando Santoro, Ignacio Melero, Antonio Cubillo Gracián, Mirelis Acosta-Rivera, Su Pin Choo, Anthony B. El-Khoueiry, Ryoko Kuromatsu, Bassel F. El‐Rayes, Kazushi Numata, Yoshito Itoh, Francesco Di Costanzo, Oxana Crysler, María Reig, Yun Shen, Jaclyn Neely, Marina Tschaika, Tami Wisniewski, Bruno Sangro

    Publicat 2021
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    hERG1 Channels Regulate VEGF-A Secretion in Human Gastric Cancer: Clinicopathological Correlations and Therapeutical Implications

    hERG1 Channels Regulate VEGF-A Secretion in Human Gastric Cancer: Clinicopathological Correlations and Therapeutical Implications per Olivia Crociani, Elena Lastraioli, Luca Boni, Serena Pillozzi, Maria Raffaella Romoli, Massimo D’Amico, Matteo Stefanini, Silvia Crescioli, Antonio Taddei, Lapo Bencini, Marco Bernini, Marco Farsi, Stefania Beghelli, Aldo Scarpa, Luca Messerini, Anna Tomezzoli, Carla Vindigni, Paolo Morgagni, Luca Saragoni, Elisa Giommoni, Silvia Gasperoni, Francesco Di Costanzo, Franco Roviello, Giovanni De Manzoni, Paolo Bechi, Annarosa Arcangeli

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer

    Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer per Emilio Bajetta, Irene Floriani, Maria Di Bartolomeo, Roberto Labianca, Alfredo Falcone, Francesco Di Costanzo, G. Comella, D. Amadori, Carmine Pinto, Chiara Carlomagno, D. Nitti, Bruno Daniele, Enrico Mini, Davide Poli, Armando Santoro, Stefania Mosconi, R. Casaretti, C. Boni, G. Pinotti, Paolo Bidoli, Lorenza Landi, Gerardo Rosati, Alessandra Ravaioli, Maurizio Cantore, Francesca Di Fabio, Enrico Aitini, Alberto Marchet, Irene Floriani, Eliana Rulli, M. Cropalato Di Tullio, Davide Poli, Francesca Galli, Elena Biagioli, Irene De Simone, Davide Poli, S. Mangano, Maurizio Tonato, Emanuele Zucca, Maria Grazia Valsecchi, Irene Floriani, Emilio Bajetta, Maria Di Bartolomeo, Roberto Labianca, D. Amadori, Alfredo Falcone, Francesco Di Costanzo, Bruno Daniele, Carmine Pinto, G. Comella, D. Nitti, Enrico Mini, Sabino De Placido, Alberto Marchet, Emilio Bajetta, Maria Di Bartolomeo, L. Catena, Massimo Schiavo, G. Pinotti, Ilaria Proserpio, Gerardo Rosati, Roberto Bordonaro, S. Cordio, Giovanni Burrafato, Anna Maria Bochicchio, Michele Aieta, Nicola Fazio, Fabio Spada, Vito Amoroso, G Marini, Héctor Soto Parrà, G. Novello, B. Massidda, Maria Teresa Ionta, Mario Comandè, R Venezia, A. Bertolini, E. Menatti, L. Zanlorenzi, Alberto Colombo, A. Iop, Salvatore Bonura, Elena Mazza, Maria Grazia Viganò, A. Ardizzoia, Stefania Dell’Oro, Giovanni Lo Re, Davide Adriano Santeufemia, Angela Buonadonna, Dimitri Luisi, G. Ucci, Giuseppe Di Lucca, Andrea Bonetti, Francesca Bergamo, Massimiliano Alú, Francesca Vastola, Paolo Marchetti, D.C. Corsi, Elena Massa, Carmine Pinto, M. Duro

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues

    Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues per Sara Pusceddu, Claudio Vernieri, Massimo Di Maïo, Riccardo Marconcini, Francesca Spada, Sara Massironi, Toni Ibrahim, Maria Pia Brizzi, Davide Campana, Antongiulio Faggiano, Dario Giuffrida, Maria Rinzivillo, Sara Cingarlini, Francesca Aroldi, Lorenzo Antonuzzo, Rossana Berardi, Laura Catena, Chiara De Divitiis, Paola Ermacora, Vittorio Perfetti, Annalisa Fontana, Paola Razzore, Carlo Carnaghi, Maria Vittoria Davì, Carolina Cauchi, Marilina Duro, Sergio Ricci, Nicola Fazio, Federica Cavalcoli, Alberto Bongiovanni, Anna La Salvia, Nicole Brighi, Annamaria Colao, Ivana Puliafito, Francesco Panzuto, Silvia Ortolani, Alberto Zaniboni, Francesco Di Costanzo, Mariangela Torniai, Emilio Bajetta, Salvatore Tafuto, Silvio Ken Garattini, Daniela Femia, Natalie Prinzi, Laura Concas, Giuseppe Lo Russo, Massimo Milione, Luca Giacomelli, Roberto Buzzoni, Gianfranco Delle Fave, Vincenzo Mazzaferro, Filippo de Braud

    Publicat 2018
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial

    Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with meta... per Chiara Cremolini, Carlotta Antoniotti, Daniele Rossini, Sara Lonardi, Fotios Loupakis, Filippo Pietrantonio, Roberto Bordonaro, Tiziana Pia Latiano, Emiliano Tamburini, Daniele Santini, Alessandro Passardi, Federica Marmorino, Roberta Grande, Giuseppe Aprile, Alberto Zaniboni, Sabina Murgioni, Cristina Granetto, Angela Buonadonna, Roberto Moretto, Salvatore Corallo, Stefano Cordio, Lorenzo Antonuzzo, Gianluca Tomasello, Gianluca Masi, M. Ronzoni, Samantha Di Donato, Chiara Carlomagno, Matteo Clavarezza, Giuliana Ritorto, Andrea Mambrini, Mario Roselli, Samanta Cupini, Serafina Mammoliti, Elisabetta Fenocchio, E. Corgna, Vittorina Zagonel, Gabriella Fontanini, Clara Ugolini, Luca Boni, Alfredo Falcone, Alfredo Falcone, Sara Lonardi, Filippo de Braud, Roberto Bordonaro, Evaristo Maiello, Emiliano Tamburini, Daniele Santini, Giovanni Luca Frassineti, Teresa Gamucci, Giuseppe Aprile, Alberto Zaniboni, Cristina Granetto, Angela Buonadonna, Francesco Di Costanzo, Gianluca Tomasello, Luca Gianni, Samantha Di Donato, Chiara Carlomagno, Matteo Clavarezza, Patrizia Racca, Andrea Mambrini, Mario Roselli, Giacomo Allegrini, Alberto Sobrero, Massimo Aglietta, E. Corgna, Enrico Cortesi, Domenico Corsi, Alberto Ballestrero, Andrea Bonetti, Francesco Clemente, Enzo Maria Ruggeri, Fortunato Ciardiello, Marco Benasso, S. Vitello, Saverio Cinieri, Stefania Mosconi, Nicola Silvestris, Antonio Frassoldati, S. Cupini, Alessandro Bertolini, Giampaolo Tortora, Carmelo Bengala, Daris Ferrari, Antonia Ardizzoia, Carlo Milandri, Silvana Chiara, Gianpiero Romano, Stefania Miraglia, Laura Scaltriti, Francesca Pucci, Livio Blasi, Silvia Brugnatelli, Luisa Fioretto, Angela Stefania Ribecco, Raffaella Longarini, M. Frisinghelli, Maria Banzi

    Publicat 2020
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: